Phase IIIB Subcutaneous Abatacept Monotherapy Study

Clinical trial NCT00547521 · COMPLETED

Trial details

NCT number: NCT00547521
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)

Start date: 2007-12-01
Primary completion: 2008-12-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.